Key highlights 1 mg lyophilized vial Freeze-dried peptide in a sterile, UV-resistant glass vial
Understanding peptides versus steroids and peptides versus SARMs helps contextualize the safety profile of peptide-based approaches relative to alternatives
Seule la consultation pralable permet dtablir un devis prcis et adapt
If a vial has been left at room temperature for an unknown duration, treat that as a documentation failure and discard it rather than guessing
The beyond-use date represents the last date a compounded preparation can be expected to maintain its labeled potency and sterility under the specified storage conditions
CJC-1295 (NO DAC) + Ipamorelin Blend Peptide Research Applications & Key Findings Growth Hormone Secretion Research Pituitary Function Studies Extensive research has examined the growth hormone secretagogue properties of the CJC-1295 + Ipamorelin combination across multiple species: Dose-dependent GH release demonstrated in rat anterior pituitary cell cultures with picomolar to micromolar peptide concentrations 2- to 10-fold increases in plasma growth hormone levels sustained for 6 days in human subjects following single CJC-1295 dose Preserved pulsatile secretion with ipamorelin addition, preventing continuous non-physiological stimulation Selective action on growth hormone release without affecting prolactin, ACTH, cortisol, FSH, or TSH levels Human trials with healthy subjects aged 21-61 years demonstrated sustained, dose-dependent increases in growth hormone and IGF-1 levels that were safe and well-tolerated at doses of 30-60 mcg/kg
